Biotech Values

[mcbio]

IDRA - addendum to prior post

One important follow-up on my comments/question at the top of my post speculating on the significance of the IMO-2125 results in HCV patients. From a big picture standpoint, I'm not sure it's really even worth wasting time discussing the significance of this drug (designed to replace interferon) inasmuch as we are presumably moving towards an all-oral HCV treatment regimen. I'm trying to save you some time Dew. ; )